title: Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
authors: Clive
authors: C
authors: Holmes
authors: David
authors: D
authors: Wilkinson
authors: Christine
authors: C
authors: Dean
authors: Corinne
authors: C
authors: Clare
authors: Mohammed
authors: M
authors: El-Okl
authors: Christine
authors: C
authors: Hensford
authors: Sheram
authors: S
authors: Moghul
mesh_terms: D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D048448:Phenylcarbamates / Q000009:adverse effects / Q000627:therapeutic use*; D011595:Psychomotor Agitation / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use*; D000068836:Rivastigmine
chemical_list: D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D018967:Risperidone; D000068836:Rivastigmine